Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.
Greystoke A, O'Connor JP, Linton K, Taylor MB, Cummings J, Ward T, Maders F, Hughes A, Ranson M, Illidge TM, Radford J, Dive C.
Greystoke A, et al.
Br J Cancer. 2011 Feb 15;104(4):719-25. doi: 10.1038/sj.bjc.6606082. Epub 2011 Jan 18.
Br J Cancer. 2011.
PMID: 21245866
Free PMC article.